BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27252517)

  • 1. Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
    Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
    Haematologica; 2016 Jun; 101(6):e271. PubMed ID: 27252517
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
    Gong Q; Wang C; Rohr J; Feldman AL; Chan WC; McKeithan TW
    Haematologica; 2016 Jun; 101(6):e269-70. PubMed ID: 27252516
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.
    Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
    Haematologica; 2016 Jun; 101(6):757-63. PubMed ID: 26819049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease.
    Popat S; Hearle N; Hogberg L; Braegger CP; O'Donoghue D; Falth-Magnusson K; Holmes GK; Howdle PD; Jenkins H; Johnston S; Kennedy NP; Kumar PJ; Logan RF; Marsh MN; Mulder CJ; Torinsson Naluai A; Sjoberg K; Stenhammar L; Walters JR; Jewell DP; Houlston RS
    Ann Hum Genet; 2002 Mar; 66(Pt 2):125-37. PubMed ID: 12174216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families.
    King AL; Moodie SJ; Fraser JS; Curtis D; Reid E; Dearlove AM; Ellis HJ; Ciclitira PJ
    J Med Genet; 2002 Jan; 39(1):51-4. PubMed ID: 11826026
    [No Abstract]   [Full Text] [Related]  

  • 6. Mice transgenic for human
    Lee GJ; Jun Y; Jeon YK; Lee D; Lee S; Kim J
    Oncoimmunology; 2022; 11(1):2015170. PubMed ID: 35003894
    [No Abstract]   [Full Text] [Related]  

  • 7. Cloning and sequence comparison of sheep CD28 and CTLA-4.
    Chaplin PJ; Pietrala LN; Scheerlinck JP
    Immunogenetics; 1999 Jun; 49(6):583-4. PubMed ID: 10380709
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study.
    Tokić S; Štefanić M; Karner I; Glavaš-Obrovac L
    Endokrynol Pol; 2017; 68(3):274-828. PubMed ID: 28660994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA fusions involving
    Vallois D; Dupuy A; Lemonnier F; Allen G; Missiaglia E; Fataccioli V; Ortonne N; Clavert A; Delarue R; Rousselet MC; Fabiani B; Llamas-Gutierrez F; Ogawa S; Thome M; Ko YH; Kataoka K; Gaulard P; de Leval L
    Haematologica; 2018 Aug; 103(8):e360-e363. PubMed ID: 29545337
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of CTLA4 and CD28 polymorphisms with lung involvement, HRCT findings and pulmonary function tests in Turkish patients with ankylosing spondylitis.
    Karakose Okyaltırık F; Rezvani A; Turan S; Uysal Ö; Yakar F; Sozgen H; Ozkan NE; Akkoyunlu ME; Bayram M; Kutbay Ozcelik H; Sezer M; Guler M; Yaylım İ; Kart L
    Clin Respir J; 2017 Sep; 11(5):593-601. PubMed ID: 26365494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.
    Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM
    Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from human lymphomas.
    Xerri L; Devilard E; Hassoun J; Olive D; Birg F
    J Pathol; 1997 Oct; 183(2):182-7. PubMed ID: 9390031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA4 gene polymorphism and autoimmunity.
    Gough SC; Walker LS; Sansom DM
    Immunol Rev; 2005 Apr; 204():102-15. PubMed ID: 15790353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy.
    Park HB; Lee JE; Oh YM; Lee SJ; Eom HS; Choi K
    Exp Mol Med; 2017 Jul; 49(7):e360. PubMed ID: 28751785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen.
    Burr JS; Kimzey SL; Randolph DR; Green JM
    Am J Respir Cell Mol Biol; 2001 May; 24(5):563-8. PubMed ID: 11350825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.
    Luterek-Puszyńska K; Malinowski D; Paradowska-Gorycka A; Safranow K; Pawlik A
    Clin Rheumatol; 2017 May; 36(5):1129-1135. PubMed ID: 27988812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Releasing the brake: CTLA-4 loss turbocharges CAR T cells.
    Schelker RC; Gattinoni L
    Immunity; 2023 Oct; 56(10):2180-2182. PubMed ID: 37820579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.
    Gmyrek GB; Pingel J; Choi J; Green JM
    Cell Immunol; 2017 Sep; 319():28-34. PubMed ID: 28711152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis.
    Croxford JL; O'Neill JK; Ali RR; Browne K; Byrnes AP; Dallman MJ; Wood MJ; Fedlmann M; Baker D
    Eur J Immunol; 1998 Dec; 28(12):3904-16. PubMed ID: 9862327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.